Caplin Point Laboratories’ subsidiary gets ANDA approval for eye drops solution

Caplin Steriles Ltd, a subsidiary of Caplin Point Laboratories Ltd, has received final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) ofloxacin ophthalmic solution USP 0.3% (eye drops).

As per the stock exchange filing, it is a generic equivalent of (RLD), OCUFLOX ophthalmic solution of Allergan Inc.

The solution is indicated for the treatment of eye infection caused by conjunctivitis and corneal ulcers.

On March 28, the company received approval for its ketorolac tromethamine ophthalmic solution 0.5% (eye drops).

Caplin Point Laboratories’ stock traded at ₹1,314.20 on the NSE, up by 1.05 per cent as of 11.16 am.

Crime Today News | Markets | Commodities | Forex | Stocks

Source | Powered by Yes Mom Hosting
Crime Today News Agency

Crime Today News

Welcome to Crime Today News, your trusted source for timely and unbiased news coverage. Since our inception in 2014, we have been dedicated to delivering the latest updates to our valued readers and viewers across Telangana.

Related Posts